AMN Healthcare Services (AMN) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.77
- Estimate
- $0.19
- Surprise
- +307.8%
- Revenue (period 2026-06-30)
- $673.2M
- Score today
- 4.9/10
Revenue source: xbrl.
How the report landed
AMN Healthcare Services (AMN) beat the $0.19 estimate with diluted EPS of $0.77 — a large 307.8% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates AMN Sell at 4.9/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +307.8% surprise compares with a +103.7% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Strong earnings beat streak (3/4)
What argues against it
- Earnings expected to decline ~65% (cyclical peak)
- Analyst target reached - limited upside remaining
- Leverage penalty (D/E 1.0): -0.5
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $34.46
- Price target
- $36.48
- Stop
- $32.05
- Upside to target
- +5.9%
Forward estimates sit below the trailing run-rate (36.8× forward vs 13.0× trailing) — consensus expects earnings to decline from here.
Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.
AMN at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $1.33B
- P/E (fwd)
- 36.8
- P/E (ttm)
- 13.0
- 52-week range
- $14.97–$37.22
- Off 52-week high
- 7.4%
- RSI (14)
- 54
- Volume vs avg
- 0.96×
- Score today
- 4.9/10